Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of intramuscular antipsychotics for rapid sedation in aggressive psychiatric emergency patients
IRCT20170212032528N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of haloperidol, promethazine, Aminazin and trifluoperazine in None (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Sedation velocity. Started Jun 2016; status: completed.
02
Drugs
haloperidolpromethazineAminazintrifluoperazine
Beyond the preview
Go deeper on IRCT20170212032528N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170212032528N2.